Terns Pharmaceuticals, Inc. — All Filings
398 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC14D9C
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 0001562180-22-004952 | Jun 8, 2022 | May 31, 2022 |
| SC 13G | NONE | 0001567619-22-012438 | Jun 7, 2022 | — |
| 8-K | 8-K | 0000950170-22-011025 | Jun 1, 2022 | — |
| 8-K | 8-K | 0000950170-22-010095 | May 16, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-010118 | May 16, 2022 | Mar 31, 2022 |
| DEF 14A | DEF 14A | 0000950170-22-006722 | Apr 29, 2022 | Jun 16, 2022 |
| DEFA14A | DEFA14A | 0000950170-22-006739 | Apr 29, 2022 | — |
| SC 13G | SCHEDULE 13G | 0001213900-22-018340 | Apr 6, 2022 | — |
| 8-K | 8-K | 0000950170-22-004229 | Mar 21, 2022 | — |
| 424B5 | 424B5 | 0001193125-22-078284 | Mar 17, 2022 | — |
| EFFECT | — | 9999999995-22-000632 | Mar 14, 2022 | — |
| UPLOAD | — | 0000000000-22-002662 | Mar 10, 2022 | — |
| CORRESP | — | 0001193125-22-071913 | Mar 10, 2022 | — |
| S-3 | S-3 | 0001193125-22-069337 | Mar 8, 2022 | — |
| S-8 | S-8 | 0001193125-22-067930 | Mar 7, 2022 | — |
| 10-K | 10-K | 0000950170-22-002962 | Mar 7, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0000950170-22-002821 | Mar 3, 2022 | — |
| SC 13G/A | — | 0001193805-22-000254 | Feb 11, 2022 | — |
| SC 13G | SCHEDULE 13G | 0001213900-22-006090 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000315066-22-001235 | Feb 9, 2022 | — |
| 4 | FORM 4 | 0001567619-22-002011 | Jan 28, 2022 | Jan 26, 2022 |
| 4 | FORM 4 | 0001567619-22-002014 | Jan 28, 2022 | Jan 26, 2022 |
| 4 | FORM 4 | 0001567619-22-002013 | Jan 28, 2022 | Jan 26, 2022 |
| 4 | FORM 4 | 0001567619-22-002012 | Jan 28, 2022 | Jan 26, 2022 |
| 8-K | 8-K | 0000950170-22-000398 | Jan 19, 2022 | — |
| 8-K | 8-K | 0000950170-21-004607 | Nov 15, 2021 | — |
| 10-Q | 10-Q | 0000950170-21-004630 | Nov 15, 2021 | Sep 30, 2021 |
| 8-K | 8-K | 0000950170-21-003784 | Nov 9, 2021 | — |
| 4 | FORM 4 | 0001567619-21-018225 | Oct 12, 2021 | Sep 28, 2021 |
| 3 | FORM 3 | 0001567619-21-018224 | Oct 12, 2021 | Sep 28, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-038538 | Sep 30, 2021 | Sep 28, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-038550 | Sep 30, 2021 | Sep 28, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-038549 | Sep 30, 2021 | Sep 28, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-038548 | Sep 30, 2021 | Sep 28, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-038545 | Sep 30, 2021 | Sep 28, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-038543 | Sep 30, 2021 | Sep 28, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-21-038540 | Sep 30, 2021 | Sep 28, 2021 |
| 8-K | 8-K | 0000950170-21-001914 | Sep 29, 2021 | Sep 28, 2021 |
| 8-K | 8-K | 0000950170-21-001495 | Aug 16, 2021 | — |
| 10-Q | 10-Q | 0000950170-21-001499 | Aug 16, 2021 | Jun 30, 2021 |
| 8-K | 8-K | 0001193125-21-190105 | Jun 14, 2021 | — |
| 10-Q | 10-Q | 0001564590-21-028052 | May 14, 2021 | Mar 31, 2021 |
| 8-K | 8-K | 0001564590-21-027565 | May 13, 2021 | — |
| SC 13G | — | 0000315066-21-001479 | Apr 12, 2021 | — |
| 10-K | 10-K | 0001564590-21-016734 | Mar 30, 2021 | Dec 31, 2020 |
| 8-K | 8-K | 0001564590-21-016704 | Mar 30, 2021 | — |
| 8-K | 8-K | 0001193125-21-063777 | Mar 1, 2021 | Feb 23, 2021 |
| 4 | FORM 4 | 0001567619-21-005068 | Feb 26, 2021 | Feb 24, 2021 |
| 4 | FORM 4 | 0001567619-21-005069 | Feb 26, 2021 | Feb 24, 2021 |
| SC 13D | SCHEDULE 13D | 0000947871-21-000256 | Feb 23, 2021 | — |